By

Bruce Kamich

 | Feb 22, 2017 | 2:29 PM EST
CHRW will do its part to lift the Dow Jones Transports in the weeks ahead.
By

Jim Cramer

 | Feb 22, 2017 | 1:57 PM EST
These may be uncharted waters, but they're not necessarily expensive.
By

James "Rev Shark" DePorre

 | Feb 22, 2017 | 1:52 PM EST
But it is all about timing, and so far there is no indication that this extended market is about to turn.
By

Bruce Kamich

 | Feb 22, 2017 | 1:16 PM EST
This is a big improvement over price declines of 2014-15.
By

Mike Norman

 | Feb 22, 2017 | 1:00 PM EST
Trend of decline in deposits is being reversed.
By

Bruce Kamich

 | Feb 22, 2017 | 12:36 PM EST
New high keeps the bull in play.
By

Tim Melvin

 | Feb 22, 2017 | 12:00 PM EST
Psychemedics and Span-America show promise for long-term growth.
By

Jim Cramer

 | Feb 22, 2017 | 11:45 AM EST
Icahn may have a tough time finding interest in this behemoth.
By

Tom Graff

 | Feb 22, 2017 | 11:30 AM EST
The stock market has priced in materially faster earnings growth, which needs a faster-growing economy.
By

Bruce Kamich

 | Feb 22, 2017 | 11:29 AM EST
The stock continues to make a turnaround.
By

Casey Hoerth

 | Feb 22, 2017 | 11:00 AM EST
Things are a lot different than five months ago.
By

James "Rev Shark" DePorre

 | Feb 22, 2017 | 10:47 AM EST
It will be interesting to see today if afternoon strength occurs once again.
By

Bruce Kamich

 | Feb 22, 2017 | 10:47 AM EST
NKE is making a slow turn on the charts.
By

Jonathan Heller

 | Feb 22, 2017 | 10:00 AM EST
Analogies to past market surges shouldn't concern investors as much as the trillions in debt we've managed to build.
By

Bret Jensen

 | Feb 22, 2017 | 10:00 AM EST
These two large-cap drug giants should be core parts of any well-diversified portfolio.
By

Bruce Kamich

 | Feb 22, 2017 | 9:55 AM EST
Buy weakness in the near term, or a close over $69.
By

Guy Ortmann

 | Feb 22, 2017 | 9:53 AM EST
Going short could prove painful at this stage of the chart setups.
By

Brian Sozzi

 | Feb 22, 2017 | 9:00 AM EST
Stay away from the retail sector.
By

Bruce Kamich

 | Feb 22, 2017 | 8:50 AM EST
MCD has better-looking technicals than just five weeks ago.
By

Skip Raschke

 | Feb 22, 2017 | 8:30 AM EST
I prefer a long call expiring next January.
By

Antonia Oprita

 | Feb 22, 2017 | 8:00 AM EST
Investing in European banks can work if you choose the right banks.
By

James "Rev Shark" DePorre

 | Feb 22, 2017 | 7:15 AM EST
While we must respect the power of this uptrend, we need to focus on managing positions.
By

Bob Byrne

 | Feb 22, 2017 | 7:00 AM EST
As well as the market's been doing, you'd think volume would be much better.
By

Paul Price

 | Feb 22, 2017 | 7:00 AM EST
Option writing provides a high probability of profitability. It also demands a decent-sized bankroll.
By

Jim Cramer

 | Feb 22, 2017 | 6:22 AM EST
The simple fact is that the consumer is still spending on housing.
On Friday NVDA opened with its second straight gap lower open as the steep pullback from t...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.